Detalles de la búsqueda
1.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Gynecol Oncol
; 164(2): 428-436, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903380
2.
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Gynecol Oncol
; 164(3): 481-491, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063278
3.
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.
Gynecol Oncol
; 161(1): 113-121, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541735
4.
Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.
Support Care Cancer
; 27(2): 531-538, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30003341
5.
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Cancer
; 123(7): 1144-1155, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27926776
6.
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
Gynecol Oncol
; 145(3): 519-525, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28392124
7.
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 141(1): 43-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27016228
8.
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.
Gynecol Oncol
; 138(1): 24-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888978
9.
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Gynecol Oncol
; 132(3): 585-92, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24456823
10.
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study.
Gynecol Oncol
; 125(1): 87-93, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22155678
11.
Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study.
Appl Immunohistochem Mol Morphol
; 30(1): 27-35, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34224438
12.
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
J Clin Oncol
; 40(9): 968-977, 2022 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35007153
13.
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
J Clin Oncol
; 40(28): 3289-3300, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658479
14.
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response.
Clin Cancer Res
; 27(10): 2734-2741, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33766814
15.
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
J Clin Oncol
; 38(33): 3841-3850, 2020 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33078978
16.
Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.
Obstet Gynecol
; 128(3): 535-542, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27500329
17.
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
J Clin Oncol
; 28(16): 2727-31, 2010 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20421537
18.
The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
Gynecol Oncol
; 106(1): 16-22, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17574073
19.
Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
Cancer
; 107(6): 1280-6, 2006 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16900525
20.
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
J Clin Oncol
; 24(1): 36-44, 2006 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16330675
Resultados
1 -
20
de 20
1
Próxima >
>>